Found: 15
Select item for more details and to access through your institution.
Efficacy of S‐1 plus docetaxel in the treatment of metastatic extramammary Paget's disease: a multicentre retrospective study.
- Published in:
- British Journal of Dermatology, 2021, v. 185, n. 2, p. 458, doi. 10.1111/bjd.20135
- By:
- Publication type:
- Article
Clinical significance of cobblestone appearance on the skin of patients with systemic sclerosis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2012, v. 26, n. 1, p. 123, doi. 10.1111/j.1468-3083.2011.04007.x
- By:
- Publication type:
- Article
Upregulated androgen receptor variant‐7 mRNA and protein in extramammary Paget's disease.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 9, p. e724, doi. 10.1111/jdv.18229
- By:
- Publication type:
- Article
Circulating phospholipase A2 group IV D DNA copies are elevated in psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 4, p. e302, doi. 10.1111/jdv.17888
- By:
- Publication type:
- Article
Genomic mutational profiling of circulating tumour DNA in metastatic angiosarcoma.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 4, p. e293, doi. 10.1111/jdv.17049
- By:
- Publication type:
- Article
The Warburg effect and tumour immune microenvironment in extramammary Paget's disease: overexpression of lactate dehydrogenase A correlates with immune resistance.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 8, p. 1715, doi. 10.1111/jdv.16145
- By:
- Publication type:
- Article
Serum cell‐free DNA levels are a useful marker for extramammary Paget disease.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 3, p. 505, doi. 10.1111/bjd.17709
- By:
- Publication type:
- Article
Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathway.
- Published in:
- British Journal of Dermatology, 2017, v. 177, n. 2, p. 456, doi. 10.1111/bjd.15303
- By:
- Publication type:
- Article
The role of PSMB9 upregulated by interferon signature in the pathophysiology of cutaneous lesions of dermatomyositis and systemic lupus erythematosus.
- Published in:
- British Journal of Dermatology, 2016, v. 174, n. 5, p. 1030, doi. 10.1111/bjd.14385
- By:
- Publication type:
- Article
Increased CCL22 expression in psoriatic skin predicts a good response to infliximab therapy.
- Published in:
- British Journal of Dermatology, 2014, v. 171, n. 5, p. 1259, doi. 10.1111/bjd.13091
- By:
- Publication type:
- Article
Impaired lymphangiogenesis due to excess vascular endothelial growth factor-D/Flt-4 signalling in the skin of patients with systemic sclerosis.
- Published in:
- British Journal of Dermatology, 2010, v. 163, n. 4, p. 776, doi. 10.1111/j.1365-2133.2010.09853.x
- By:
- Publication type:
- Article
Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
- Published in:
- British Journal of Dermatology, 2010, v. 162, n. 4, p. 751, doi. 10.1111/j.1365-2133.2009.09567.x
- By:
- Publication type:
- Article
Retrospective study of COL1A1‐PDGFB fusion gene‐positive dermatofibrosarcoma protuberans in Kumamoto University.
- Published in:
- Clinical & Experimental Dermatology, 2020, v. 45, n. 8, p. 1067, doi. 10.1111/ced.14312
- By:
- Publication type:
- Article
The miR-146a rs2910164 C/G polymorphism is associated with telangiectasia in systemic sclerosis.
- Published in:
- Clinical & Experimental Dermatology, 2013, v. 38, n. 1, p. 99, doi. 10.1111/j.1365-2230.2012.04453.x
- By:
- Publication type:
- Article
Circulating miR-142-3p levels in patients with systemic sclerosis.
- Published in:
- Clinical & Experimental Dermatology, 2012, v. 37, n. 1, p. 34, doi. 10.1111/j.1365-2230.2011.04158.x
- By:
- Publication type:
- Article